PT98190A - Processo para a preparacao de composicoes farmaceuticas para estabilizar o plasma sanguineo durante a pasteurizacao - Google Patents

Processo para a preparacao de composicoes farmaceuticas para estabilizar o plasma sanguineo durante a pasteurizacao

Info

Publication number
PT98190A
PT98190A PT98190A PT9819091A PT98190A PT 98190 A PT98190 A PT 98190A PT 98190 A PT98190 A PT 98190A PT 9819091 A PT9819091 A PT 9819091A PT 98190 A PT98190 A PT 98190A
Authority
PT
Portugal
Prior art keywords
blood plasma
preparation
pharmaceutical compositions
stabilizing blood
plasma during
Prior art date
Application number
PT98190A
Other languages
English (en)
Other versions
PT98190B (pt
Inventor
Myriana Burnouf
Thierry Burnouf
Original Assignee
Centre Regional De Transfusion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Regional De Transfusion filed Critical Centre Regional De Transfusion
Publication of PT98190A publication Critical patent/PT98190A/pt
Publication of PT98190B publication Critical patent/PT98190B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/04—Heat
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6443—Coagulation factor XIa (3.4.21.27)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21027—Coagulation factor XIa (3.4.21.27)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials
    • A61L2103/09—Blood or products thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
PT98190A 1990-07-03 1991-07-02 Processo para a preparacao de composicoes farmaceuticas para estabilizar o plasma sanguineo durante a pasteurizacao PT98190B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9008375A FR2664165B1 (fr) 1990-07-03 1990-07-03 Composition pour stabiliser le plasma sanguin en cours de pasteurisation.

Publications (2)

Publication Number Publication Date
PT98190A true PT98190A (pt) 1992-05-29
PT98190B PT98190B (pt) 1998-12-31

Family

ID=9398269

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98190A PT98190B (pt) 1990-07-03 1991-07-02 Processo para a preparacao de composicoes farmaceuticas para estabilizar o plasma sanguineo durante a pasteurizacao

Country Status (22)

Country Link
EP (1) EP0497929B1 (pt)
JP (1) JP3132828B2 (pt)
AT (1) ATE135238T1 (pt)
AU (1) AU8062991A (pt)
CA (1) CA2065284A1 (pt)
CZ (1) CZ281431B6 (pt)
DE (1) DE69117920T2 (pt)
DK (1) DK0497929T3 (pt)
ES (1) ES2084821T3 (pt)
FI (1) FI96918C (pt)
FR (1) FR2664165B1 (pt)
GR (1) GR3020048T3 (pt)
HU (1) HU208404B (pt)
LT (1) LT3419B (pt)
LV (1) LV10384B (pt)
NO (1) NO179127C (pt)
PL (1) PL166579B1 (pt)
PT (1) PT98190B (pt)
RU (1) RU2045902C1 (pt)
SK (1) SK279031B6 (pt)
WO (1) WO1992000767A1 (pt)
ZA (1) ZA914848B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2687317B1 (fr) 1992-02-13 1995-06-23 Aetsrn Composition pour stabiliser le plasma sanguin en cour de pasteurisation et solution plasmatique pasteurisee a usage therapeutique.
DE4240103A1 (de) * 1992-05-26 1993-12-02 Behringwerke Ag Verfahren zur Inaktivierung von Viren in Präparationen von Proteinen
DE19508192A1 (de) * 1995-03-09 1996-09-12 Behringwerke Ag Stabile Transglutaminasepräparate und Verfahren zu ihrer Herstellung
US20060019234A1 (en) * 2004-07-22 2006-01-26 Shanbrom Technologies, Llc Modern blood banking employing improved cell preservation composition
WO2017155678A1 (en) 2016-03-10 2017-09-14 Kindheart, Inc Fake blood for use in simulated surgical procedures

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2916711A1 (de) 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung
DE3176491D1 (en) 1980-03-05 1987-11-26 Miles Lab Pasteurized therapeutically active protein compositions
DE3045153A1 (de) * 1980-11-29 1982-07-08 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung von blutgerinnungsfaktoren und danach hergestellte praeparation der faktoren ix und x
DE3336631A1 (de) * 1983-10-08 1985-04-18 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von plasma oder von konzentraten der blutgerinnungsfaktoren ii, vii, ix und x
US4543210A (en) * 1984-10-04 1985-09-24 Miles Laboratories, Inc. Process for producing a high purity antihemophilic factor concentrate
DK18288D0 (da) * 1988-01-15 1988-01-15 Nordisk Gentofte Fremgangsmaade til pasteurisering af vandige oploesninger af faktor viii

Also Published As

Publication number Publication date
PL166579B1 (pl) 1995-06-30
EP0497929A1 (fr) 1992-08-12
LV10384A (lv) 1995-02-20
DK0497929T3 (da) 1996-07-22
FR2664165A1 (fr) 1992-01-10
PL294037A1 (en) 1993-01-11
AU8062991A (en) 1992-02-04
CZ281431B6 (cs) 1996-09-11
NO920791L (no) 1992-02-28
HUT60148A (en) 1992-08-28
DE69117920T2 (de) 1996-10-02
CS57992A3 (en) 1992-08-12
DE69117920D1 (de) 1996-04-18
ATE135238T1 (de) 1996-03-15
EP0497929B1 (fr) 1996-03-13
HU9200701D0 (en) 1992-05-28
NO179127C (no) 1996-08-14
PT98190B (pt) 1998-12-31
FI96918C (fi) 1996-09-25
JPH05501417A (ja) 1993-03-18
NO179127B (no) 1996-05-06
GR3020048T3 (en) 1996-08-31
RU2045902C1 (ru) 1995-10-20
WO1992000767A1 (fr) 1992-01-23
ES2084821T3 (es) 1996-05-16
NO920791D0 (no) 1992-02-28
LTIP264A (en) 1994-10-25
HU208404B (en) 1993-10-28
JP3132828B2 (ja) 2001-02-05
LT3419B (en) 1995-09-25
SK279031B6 (sk) 1998-05-06
FI920934A0 (fi) 1992-03-02
FI96918B (fi) 1996-06-14
FR2664165B1 (fr) 1992-10-16
CA2065284A1 (fr) 1992-01-04
LV10384B (en) 1995-04-20
ZA914848B (en) 1992-04-29

Similar Documents

Publication Publication Date Title
ATE76748T1 (de) Arzneimittel fuer den bereich der mundhoehle.
ES554967A0 (es) Un procedimiento para preparar una formulacion farmaceutica que contiene un 2'3'-didesoxi-nucleosido.
FI913478A0 (fi) Diazinderivat.
PT88930A (pt) Processo para a preparacao de novos analogos de nucleosidos e de composicoes farmaceuticas que os contem
SE8406538D0 (sv) Novel derivatives of purine
NO902800L (no) Fremgangsmaate for fremstilling av 11beta-aryl-4-oestrener.
ES2121065T3 (es) Composicion para estabilizar el plasma sanguineo durante el pasteurizado y procedimiento de pasteurizado que comprende la utilizacion de esta composicion.
IT8322855A0 (it) Composizione farmaceutica per la cura delle arteriopatie periferiche.
AU584235B2 (en) New tricyclic compounds, processes for the preparation thereof and pharmaceutical compositions containing them
ATE124681T1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
ATE93388T1 (de) Paracetamol enthaltende arzneizubereitung.
DK0497929T3 (da) Præparat til stabilisering af blodplasma under pasteurisering
DK116386D0 (da) Polyprenylforbindelser, fremgangsmaader til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne
ZA81927B (en) Phenylpiperazine derivatives of 1,3,4-oxadiazolyphenols their preparation and therapeutic agents containing these compounds
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
SE8402199L (sv) Farmaceutiskt preparat innehallande co-dergocrin och en kalciumantagonist
DE3464486D1 (en) Derivatives of n-(4-acetylaminophenacyl)-amine, their therapeutical use and process for their preparation
DK598184A (da) 3-aryl-1,2-benzisoxazolsulfonyl- og -sulfinylalkansyrer og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse som laegemidler

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920313

FG3A Patent granted, date of granting

Effective date: 19980929

PC4A Transfer of assignment

Owner name: ETABLISSEMENT FRANCAIS DU SANG, FR

Effective date: 20100305

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20120329